Clinical activity and safety of cevostamab in relapsed/refractory multiple myeloma

Pregnancy outcomes in breast cancer survivors; meta-analysis

ASCEMBL: Asciminib for hard-to-treat chronic myeloid leukaemia

ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM

Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukaemia: results of the ITCC-059 study

MURANO: Sustained disease survival in CLL following venetoclax plus rituximab

Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk CLL

OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020

Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma

ASH 2020: Targeted therapies in r/r multiple myeloma

Peripheral blood CD26 leukaemia stem cell monitoring in CML during TKI treatment

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings